Professor Adrian Hobbs holds a Chair in Cardiovascular Pharmacology at the William Harvey Research Institute, Queen Mary University of London. His research interests revolve around the cardiac and vascular pharmacology of nitric oxide and natriuretic peptides; fields in which he has published more than 200 articles attracting greater than 13000 citations. Adrian obtained his BSc (1st, 1989) and PhD (1992) in Pharmacology from King’s College London, and subsequently received a Fulbright-Hays Fellowship to work at the University of California, Los Angeles (1993). He returned to the UK in 1996 and was the recipient of Wellcome Trust Career Development and Senior Fellowship Awards at University College London before becoming a Reader in 2007. Adrian is a Fellow of the British Pharmacological Society (2016) and been a member since 1996; he has also served on the Membership & Awards Committee (2014-2020) and as an Editor for the British Journal of Pharmacology (2000-2005). In 2004 he received the BPS Novartis Prize. Adrian is Senior Editor for the Nitric Oxide Journal (2016-) and Chair of an International Union of Basic and Clinical Pharmacology nomenclature committee (2014-), and a member of the International Cyclic GMP Conference organising team (2014-).